Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q27473252)
Watch
English
Multilaboratory Comparison of Hepatitis C Virus Viral Load Assays
scientific article
In more languages
edit
Statements
instance of
scholarly article
0 references
title
Multilaboratory Comparison of Hepatitis C Virus Viral Load Assays
(English)
0 references
main subject
virology
0 references
viral load
1 reference
based on heuristic
inferred from title
Hepatitis C virus
1 reference
based on heuristic
inferred from title
hepatitis C
1 reference
based on heuristic
inferred from title
author name string
A M Caliendo
series ordinal
1
0 references
A Valsamakis
series ordinal
2
0 references
Y Zhou
series ordinal
3
0 references
B Yen-Lieberman
series ordinal
4
0 references
J Andersen
series ordinal
5
0 references
S Young
series ordinal
6
0 references
A Ferreira-Gonzalez
series ordinal
7
0 references
G J Tsongalis
series ordinal
8
0 references
R Pyles
series ordinal
9
0 references
J W Bremer
series ordinal
10
0 references
N S Lurain
series ordinal
11
0 references
language of work or name
English
0 references
publication date
May 2006
0 references
published in
Journal of Clinical Microbiology
0 references
volume
44
0 references
issue
5
0 references
page(s)
1726-32
0 references
cites work
Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 Assays
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
21 March 2017
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
21 March 2017
Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
21 March 2017
Statistical methods for assessing agreement between two methods of clinical measurement
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
21 March 2017
Performance characteristics of a quantitative TaqMan hepatitis C virus RNA analyte-specific reagent
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
29 September 2017
Verification of an assay for quantification of hepatitis C virus RNA by use of an analyte-specific reagent and two different extraction methods
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
29 September 2017
Multicenter evaluation of the performance characteristics of the bayer VERSANT HCV RNA 3.0 assay (bDNA)
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
29 September 2017
Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group virology laboratories
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
29 September 2017
Prognostic factors and early predictability of sustained viral response with peginterferon alfa-2a (40KD).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
27 November 2018
Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1479213
retrieved
27 November 2018
Identifiers
DOI
10.1128/JCM.44.5.1726-1732.2006
0 references
PMCID
1479213
0 references
PubMed ID
16672399
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
